The efficacy of rivaroxaban when compared with warfarin for the prevention of stroke or systemic embolism was similar in patients with PAD ( HR : @ , @ % CI : @-@ @ ) and without PAD ( HR : @ , @ % CI : @-@ @ ; interaction P = @ ) .